Specialist chemotherapy eprescribing, providing a complete end-to-end solution that includes predefined regimens, prescribing, scheduling and dispensing, through to chemotherapy administration and reporting.
iQemo simplifies the prescribing of complex treatments through its intuitive user interface, so our users can spend more time with patients and less time writing prescriptions. Our cloud-based platform can be securely accessed from anywhere, providing up-to-date clinical information on any device with a web browser.
I find iQemo the best out of the four eprescribing systems I use
The iQemo integration engine can be configured to integrate directly into a hospital PAS system. When a patient is referred to an oncology or haematology consultant, their referral details can be automatically imported directly into iQemo, ready for their treatment plan to be created.
Manually entering patient demographic information is time consuming and increases the risk of duplicate records. The iQemo integration engine solves this.
iQemo is designed and developed to meet the everyday needs of our clinical users, so they can better support the patients in their care.
“I have been using iQemo for approximately 12 months. The system is extremely easy to use and intuitive. Addition or subtraction of medications and changing of cycles is simple. The support from iQemo has been exceptional, from building new regimens to adapting those to make prescriptions more simple.”
“Clear, legible and legal prescriptions means fewer interventions are made by pharmacy as we have fewer errors. Ultimately this saves us time. Pharmacy approved templates linked to protocols provide a seamless flow of information that is clinically accurate. Most appropriate antiemetics and TTOs for each regimen ensure patients receive the best level of care and reduced errors.”
“iQemo has given me more time in my working day. I no longer have to chase consultants trying to obtain signed prescriptions. I have instant knowledge of when a prescription is prescribed”
You need your clinical systems to be reliable, safe and responsive. iQemo is built on industry-leading technologies and platforms, to ensure our systems are secure, resilient, high-performing and scalable.
Load-balanced and redundant hosting ensures almost constant availability, across systems that are regularly penetration tested to ensure a secure and robust environment.
Biosimilar switching is becoming more common as Rituximab, Trastuzumab and Bevacizumab all have biosimilars on the market. Due to stock shortages and contract prices, there may be a need to switch biosimilars more regularly. This will become more common as additional biosimilar products come to the market. iQemo can facilitate biosimilar switching through several mechanisms.Read more
Beyond the standard benefits of e-prescribing, iQemo provides many additional features that will help your organisation further improve the safety of its patients receiving chemotherapy.Read more
An explanation of the iQemo settings hierarchy, from drug-formulary to drug-level, and how that relates to dose capping.Read more
Sign up to our newsletter and stay updated with industry-leading advice, insight and more…